Home›Companies›Biotech & Pharma›Capsulomics

Capsulomics, Inc.

Updated Oct 29, 2026·Latest SEC filing Mar 19, 2025·Suggest an edit

About Capsulomics

Capsulomics is a private company based in Halethorpe, Maryland. It has reported $2,392,270 raised in one offering on Form D since January 2020. Its chief executive is Daniel Lunz.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 17, 2019Jan 22, 2020amended Mar 19, 2025$2,392,270of $3.0M target10$239KSimple Agreement for Future Equity [SAFE]Rule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Capsulomics's Form D filed Mar 19, 2025.

DL
Daniel Lunz
Chief Executive Officer and director
WS
William Stevens
Executive officer
SM

Sources

  1. SECCapsulomics, Inc. Form D, filed Jan 22, 2020
  2. SECCapsulomics, Inc. filing history